Nanomedicines targeting metabolism in the tumor microenvironment

HIGHLIGHTS

• who: Jiaojiao Xu et al. from the United States University of Maryland, United States have published the research work: Nanomedicines Targeting Metabolism in the Tumor Microenvironment, in the Journal: (JOURNAL)

SUMMARY

Metabolic reprogramming, a hallmark of cancer, is considered to be one of their driving forces. It endows cancer cells with the potential for initiation and proliferation in the nutrient-deficient tumor microenvironment (TME) (Yoshida, 2015; Martínez-Reyes and Chandel, 2021). Cancer cells usually abandon the efficient metabolic pathway used by most normal cells and switch to alternative pathways that produce less . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.